Physician profile
Daniel Aghion
NPI 1700045234
$16,681.02
in general payments reported to CMS, 2019-2025
7 companies · $4,449 in 2025
The $4,449 reported for 2025 was more than what 79% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,272 · 2020: $655 · 2022: $343 · 2023: $542 · 2024: $8,420 · 2025: $4,449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $1,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,000.00 |
| Food and Beverage | $1,410.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $15,849.69 | 2019-2025 | Spinejack, Niagara Lateral Access System, Capri Corpectomy Cage System |
| Vb Spine LLC | $397.14 | 2025 | Chesapeake Stabilization System, Avs Anchor-C, Everest Spinal System |
| Alphatec Spine, INC | $243.32 | 2023 | Other - Miscellaneous |
| Depuy Synthes Sales INC. | $121.87 | 2019 | |
| Smith+Nephew, INC. | $44.55 | 2025 | Pico 14 |
| Orthofix Medical, INC. | $12.29 | 2022 | |
| Zimmer Biomet Holdings, INC. | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Aghion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.